EMPA-ESUS. A randomised control trial to investigate the impact of Empagliflozin on left atrial function in patients with embolic stroke of undetermined source (360G-Wellcome-317473_Z_24_Z)

£0

Atrial fibrillation (AF) is the most common arrhythmia in the adult population. Despite this, preventing AF remains an unmet need. This is particularly important in populations at risk of AF development, such as individuals who suffer an embolic stroke of undetermined source (ESUS). ESUS represents approximately 17% of patients with ischaemic stroke, in whom an aetiology is not identified. We have demonstrated that more than 40% of ESUS patients develop AF if monitored with an implantable loop recorder (ILR). It has been suggested that Empagliflozin can cause a significant reduction in AF, as high as 48% based on analysis of previous studies. The aim of this project is to assess whether treatment with Empagliflozin impacts left atrial strain, which is considered an important predictor for future AF. We propose a pragmatic randomised control trial. A total of 100 patients with ESUS undergoing ILR implantation will be recruited. Participants will be randomised either to 6-months of empaglaflozin and usual stroke care, or usual stroke care alone. Data from the ILR will be reviewed on a regular basis, and participants will undergo electrocardiography and echocardiography at baseline and at the end of the study period.

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Region East of England
Award Date 2024-09-30T00:00:00+00:00
Sponsor(s) Prof Vassilios Vassiliou
Internal ID 317473/Z/24/Z
Planned Dates: End Date 2026-10-23T00:00:00+00:00
Planned Dates: Start Date 2023-09-06T00:00:00+00:00
Amount Awarded 0 info icon
Financial Year 2023/24
Lead Applicant Dr Rahul Kumar Chattopadhyay
Grant Programme: Title PhD Studentship for Health Professionals
Applicant Surname Chattopadhyay
Approval Committee Discretionary Award decision meeting
Recipient Org: Country United Kingdom
Recipient Org: City Cambridge
Has the grant transferred? No
Research conducted at multiple locations? No
Total amount including partnership funding 0

Help shape the next 10 years of GrantNav!

GrantNav is celebrating its 10th anniversary. Take our quick 3-minute survey to tell us how we can make the data work better for you.

Take the Survey